Related Experiment Video
Updated: May 9, 2026
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Renal anemia: from incurable to curable
154 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan. motoy@kuhp.kyoto-u.ac.jp.
American Journal of Physiology. Renal Physiology
|July 26, 2013
Summary
Renal anemia, often caused by low erythropoietin (EPO), is treated with recombinant human EPO (rhEPO). This review explores rhEPO drawbacks and discusses endogenous EPO regulation for new therapeutic strategies.
Area of Science:
- Nephrology
- Hematology
- Pharmacology
Background:
- Renal anemia is a common complication of chronic kidney disease (CKD).
- The primary cause of renal anemia is insufficient erythropoietin (EPO) production.
- Current treatments involve recombinant human EPO (rhEPO), but carry risks and costs.
Purpose of the Study:
- To review current treatments for renal anemia and their limitations.
- To provide an overview of erythropoietin (EPO) regulation in health and disease.
- To propose future therapeutic strategies targeting the pathophysiology of renal anemia.
Main Methods:
- Literature review of renal anemia treatments.
- Analysis of erythropoietin (EPO) physiological and pathophysiological regulation.
- Discussion of potential endogenous EPO induction therapies.
Main Results:
- Recombinant human EPO (rhEPO) is effective but associated with increased mortality risks and economic burden.
- The precise regulation of EPO in both healthy and diseased states remains incompletely understood.
- Developing endogenous EPO inducers presents a promising alternative to rhEPO.
Conclusions:
- Current rhEPO treatments for renal anemia have significant drawbacks.
- Further research into EPO regulation is crucial for developing novel therapeutic approaches.
- Targeting endogenous EPO production offers a potential path to safer and more effective renal anemia management.
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...